Follicle-Stimulating Hormone Receptor (FSHR) Ser680Asn Genotype Does Not Affect the Follicular Fluid Hormonal Profile in Stimulated Cycles Using Different Gonadotropin Preparations for Ovulation Induction: A Pilot Study

Overview

Journal Cureus

Specialty Biomedical Engineering

Date 2024 Jun 12

PMID 38863774

Authors

Myrto-Sotiria Papamentzelopoulou

Despoina Mavrogianni

Emmanouela Liokari

Sofoklis Stavros

Anastasios Potiris

Dimitris Doumplis

Dimitrios Loutradis

Affiliations

Soon will be listed here.

Abstract

Background: The existing literature lacks consensus on the effectiveness of utilizing polymorphisms to enhance outcomes in in vitro fertilization (IVF), particularly regarding ovulation induction protocols, oocyte and embryo quality, and pregnancy rates. Therefore, the present pilot study aims to assess whether the composition of different gonadotropin preparations affects the ovarian stimulation protocol concerning follicle-stimulating hormone receptor () Ser680Asn genotypes (Ser/Ser, Ser/Asn, and Asn/Asn), in terms of ovulation induction parameters, including oocyte maturation rate, embryo quality, and pregnancy rate.

Methodology: A total of 94 IVF patients underwent treatment using a GnRH antagonist protocol with four distinct gonadotropin preparations: HMG, HMG/hCG, rFSH, and rFSH/hCG. Follicular fluid (FF) samples were pooled for each patient for analysis.

Results: No statistical differences in the FF hormonal profile (progesterone, testosterone, androstenedione, estradiol, FSH, hCG) among the genotypes were reported either separately for each protocol or in combination for the four different preparations of gonadotropins. The maturation rate of MII oocytes and embryo quality did not differ among women carrying either Ser/Ser, Ser/Asn, or Asn/Asn genotype (p-value=0.475, and p-value=1.000, respectively). Moreover, no statistically significant correlation was revealed among Ser/Ser, Ser/Asn, and Asn/Asn carriers and pregnancy rate (p = 0.588).

Conclusions: FF hormonal analysis of women undergoing IVF using different ovulation induction protocols and carrying either Ser/Ser, Ser/Asn, or Asn/Asn genotype revealed no significant correlations, in terms of maturation rate of MII oocytes, embryo quality, and pregnancy rate, indicating that the Ser680Asn genotype does not constitute a biomarker for a positive pregnancy outcome. Therefore, the existence of a different mechanism for the expression of Ser680Asn genotypes in the FF hormonal profile related to stimulated cycles is implied.

References

van Wely M, Kwan I, Burt A, Thomas J, Vail A, van der Veen F . Recombinant versus urinary gonadotrophin for ovarian stimulation in assisted reproductive technology cycles. Cochrane Database Syst Rev. 2011; (2):CD005354. PMC: 7388278. DOI: 10.1002/14651858.CD005354.pub2. View

Basuray R, Rawlins R, Radwanska E, Henig I, Sachdeva S, Tummon I . High progesterone/estradiol ratio in follicular fluid at oocyte aspiration for in vitro fertilization as a predictor of possible pregnancy. Fertil Steril. 1988; 49(6):1007-11. DOI: 10.1016/s0015-0282(16)59952-x. View

Sudo S, Kudo M, Wada S, Sato O, Hsueh A, Fujimoto S . Genetic and functional analyses of polymorphisms in the human FSH receptor gene. Mol Hum Reprod. 2002; 8(10):893-9. DOI: 10.1093/molehr/8.10.893. View

Loutradis D, Vlismas A, Drakakis P, Antsaklis A . Pharmacogenetics in ovarian stimulation--current concepts. Ann N Y Acad Sci. 2008; 1127:10-9. DOI: 10.1196/annals.1434.001. View

Borgbo T, Kluckova H, Macek Sr M, Chrudimska J, Kristensen S, Hansen L . The Common Follicle-Stimulating Hormone Receptor (FSHR) Promoter Polymorphism FSHR -29G > A Affects Androgen Production in Normal Human Small Antral Follicles. Front Endocrinol (Lausanne). 2017; 8:122. PMC: 5454067. DOI: 10.3389/fendo.2017.00122. View

Yao Y, Ma C, Tang H, Hu Y . Influence of follicle-stimulating hormone receptor (FSHR) Ser680Asn polymorphism on ovarian function and in-vitro fertilization outcome: a meta-analysis. Mol Genet Metab. 2011; 103(4):388-93. DOI: 10.1016/j.ymgme.2011.04.005. View

Loutradis D, Drakakis P, Kallianidis K, Milingos S, Dendrinos S, Michalas S . Oocyte morphology correlates with embryo quality and pregnancy rate after intracytoplasmic sperm injection. Fertil Steril. 1999; 72(2):240-4. DOI: 10.1016/s0015-0282(99)00233-2. View

Pabalan N, Trevisan C, Peluso C, Jarjanazi H, Christofolini D, Barbosa C . Evaluating influence of the genotypes in the follicle-stimulating hormone receptor (FSHR) Ser680Asn (rs6166) polymorphism on poor and hyper-responders to ovarian stimulation: a meta-analysis. J Ovarian Res. 2014; 7:285. PMC: 4279698. DOI: 10.1186/s13048-014-0122-2. View

Borgbo T, Jeppesen J, Lindgren I, Lundberg Giwercman Y, Hansen L, Andersen C . Effect of the FSH receptor single nucleotide polymorphisms (FSHR 307/680) on the follicular fluid hormone profile and the granulosa cell gene expression in human small antral follicles. Mol Hum Reprod. 2014; 21(3):255-61. DOI: 10.1093/molehr/gau106. View

10.

Casarini L, Brigante G, Simoni M, Santi D . Clinical Applications of Gonadotropins in the Female: Assisted Reproduction and Beyond. Prog Mol Biol Transl Sci. 2016; 143:85-119. DOI: 10.1016/bs.pmbts.2016.08.002. View

11.

Anagnostou E, Mavrogianni D, Theofanakis C, Drakakis P, Bletsa R, Demirol A . ESR1, ESR2 and FSH receptor gene polymorphisms in combination: a useful genetic tool for the prediction of poor responders. Curr Pharm Biotechnol. 2011; 13(3):426-34. DOI: 10.2174/138920112799361891. View

12.

Perez Mayorga M, Gromoll J, Behre H, Gassner C, Nieschlag E, Simoni M . Ovarian response to follicle-stimulating hormone (FSH) stimulation depends on the FSH receptor genotype. J Clin Endocrinol Metab. 2000; 85(9):3365-9. DOI: 10.1210/jcem.85.9.6789. View

13.

de Castro F, Ruiz R, Montoro L, Perez-Hernandez D, Padilla E, Real L . Role of follicle-stimulating hormone receptor Ser680Asn polymorphism in the efficacy of follicle-stimulating hormone. Fertil Steril. 2003; 80(3):571-6. DOI: 10.1016/s0015-0282(03)00795-7. View

14.

Hillier S, De Zwart F . Evidence that granulosa cell aromatase induction/activation by follicle-stimulating hormone is an androgen receptor-regulated process in-vitro. Endocrinology. 1981; 109(4):1303-5. DOI: 10.1210/endo-109-4-1303. View

15.

Gromoll J, Simoni M . Genetic complexity of FSH receptor function. Trends Endocrinol Metab. 2005; 16(8):368-73. DOI: 10.1016/j.tem.2005.05.011. View

16.

Thuesen L, Nyboe Andersen A, Loft A, Smitz J . Intrafollicular endocrine milieu after addition of hCG to recombinant FSH during controlled ovarian stimulation for in vitro fertilization. J Clin Endocrinol Metab. 2013; 99(2):517-26. DOI: 10.1210/jc.2013-1528. View

17.

Simoni M, Casarini L . Mechanisms in endocrinology: Genetics of FSH action: a 2014-and-beyond view. Eur J Endocrinol. 2013; 170(3):R91-107. DOI: 10.1530/EJE-13-0624. View

18.

Loutradis D, Patsoula E, Minas V, Koussidis G, Antsaklis A, Michalas S . FSH receptor gene polymorphisms have a role for different ovarian response to stimulation in patients entering IVF/ICSI-ET programs. J Assist Reprod Genet. 2006; 23(4):177-84. PMC: 3454958. DOI: 10.1007/s10815-005-9015-z. View

19.

Greb R, Behre H, Simoni M . Pharmacogenetics in ovarian stimulation - current concepts and future options. Reprod Biomed Online. 2006; 11(5):589-600. DOI: 10.1016/s1472-6483(10)61167-4. View

20.

Smitz J, Andersen A, Devroey P, Arce J . Endocrine profile in serum and follicular fluid differs after ovarian stimulation with HP-hMG or recombinant FSH in IVF patients. Hum Reprod. 2006; 22(3):676-87. DOI: 10.1093/humrep/del445. View